Inicio › Cáncer de próstata › Arizona
Ensayos clínicos de Cáncer de próstata en Arizona
43 estudios sobre Cáncer de próstata buscan participantes en Arizona.
Ciudades en Arizona
Texto oficial del estudio (inglés)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Cancer Center at Saint Joseph's, Phoenix
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 13 nov 2026 · NCT04423211Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Mayo Clinic Hospital in Arizona, Phoenix
- Mayo Clinic in Arizona, Scottsdale
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03866382Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Mayo Clinic, Scottsdale
Reclutando
Edades de 18 en adelante · Hombres · Actualizado el 12 nov 2026 · NCT06511141WATER IV PCa (AS Sub-study)
- Arizona State Urological Institute, Chandler
Reclutando
Edades de 45 en adelante · Hombres · Actualizado el 6 nov 2026 · NCT07650448A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
- Honor Health Research Institute, Scottsdale
ReclutandoFase 1/2
Edades de 18 en adelante · Hombres · Actualizado el 5 nov 2026 · NCT07567846Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Kingman Regional Medical Center, Kingman
- Cancer Center at Saint Joseph's, Phoenix
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06632977Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT06931340A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
- HonorHealth, Scottsdale
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT05800665A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Mayo Clinic in Arizona - Phoenix ( Site 0044), Phoenix
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 30 oct 2026 · NCT06925737Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Mayo Clinic, Phoenix
ReclutandoFase 1
Edades de 18 a 100 · Hombres · Actualizado el 29 oct 2026 · NCT05519449A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 111, Tucson
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 oct 2026 · NCT05914116A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- The University of Arizona Cancer Center - North Campus ( Site 0073), Tucson
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 oct 2026 · NCT06136650A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- City of Hope Cancer Center Phoenix, Goodyear
- University of Arizona Cancer Center, Tucson
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 20 oct 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- University of Arizona, Tucson
ReclutandoFase 3
Edades de 18 a 100 · Hombres · Actualizado el 15 oct 2026 · NCT06855277A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Phoenix
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 14 oct 2026 · NCT06952803This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Chandler
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Gilbert
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Glendale
- y 5 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 14 oct 2026 · NCT07028853Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
- Mayo Clinic in Arizona, Scottsdale
ReclutandoFase 1 temprana
Edades de 18 en adelante · Hombres · Actualizado el 13 oct 2026 · NCT05045066Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Banner MD Anderson Cancer Center, Gilbert
- Cancer Center at Saint Joseph's, Phoenix
- University of Arizona Cancer Center-Orange Grove Campus, Tucson
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 8 oct 2026 · NCT03678025FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Mayo Clinic, Phoenix
- Honor Health, Scottsdale
- Arizona Cancer Center at University of Arizona, Tucson
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 oct 2026 · NCT05919264A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
- GSK Investigational Site, Phoenix
ReclutandoFase 1/2
Edades de 18 en adelante · Hombres · Actualizado el 5 oct 2026 · NCT06990880Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
- Mayo Clinic in Arizona, Scottsdale
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 2 oct 2026 · NCT06625034Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- Mayo Clinic, Scottsdale
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 29 sept 2026 · NCT01492972DESTINY-PANTUMOUR04
- Research Site, Bullhead City
- Research Site, Casa Grande
ReclutandoEstudio observacional
Edades de 18 a 130 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07124000Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
- Mayo Clinic in Arizona, Scottsdale
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 23 sept 2026 · NCT07025369Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Honor Health Research Institute, Scottsdale
ReclutandoFase 2/3
Edades de 18 a 100 · Hombres · Actualizado el 22 sept 2026 · NCT06780670A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
- Academic Urology and Urogynecology of Arizona, Peoria
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 15 sept 2026 · NCT07332000Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Mayo Clinic- Phoenix, Phoenix
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 11 sept 2026 · NCT06056830A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Western Regional Medical Center - City of Hope Phoenix Goodyear, Goodyear
- HonorHealth Research Institute, Scottsdale
- The University of Arizona Cancer Center - North Campus, Tucson
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 17 ago 2026 · NCT06842498Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #108, Goodyear
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 jul 2026 · NCT06545942PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
- Banner MD Anderson, Gilbert
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 22 jul 2026 · NCT06274047Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
- Mayo Clinic in Arizona, Phoenix
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 20 jul 2026 · NCT06378866Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Cancer Center at Saint Joseph's, Phoenix
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 14 jul 2026 · NCT06592924Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Mayo Clinic Arizona, Scottsdale
ReclutandoFase 4
Edades de 18 a 100 · Hombres · Actualizado el 4 jun 2026 · NCT05803941A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
- Honor Health, Scottsdale
ReclutandoFase 1/2
Edades de 18 en adelante · Hombres · Actualizado el 4 jun 2026 · NCT06609005A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Mayo Clinic, Phoenix
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 mar 2026 · NCT06395519Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
- Arizona Urology Specialists, Tucson
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 19 feb 2026 · NCT06450106A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- HonorHealth Research Institute, Scottsdale
- The University of Arizona Cancer Center, Tucson
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 feb 2026 · NCT06778863Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Cancer Center at Saint Joseph's, Phoenix
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 29 ene 2026 · NCT05806515Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Scottsdale Medical Imaging, LLC, Scottsdale
ReclutandoFase 4
Edades de 18 a 64 · Todos los sexos · Actualizado el 22 ene 2026 · NCT04373564De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.